Translational Health Economics

Wolf Rogowski, Jürgen John, Maarten Joost IJzerman

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Translational health economics (THE) can be defined as the use of theoretical concepts and empirical methods in health economics to bridge the gap between the decision to fund and use a new health technology in clinical practice (the backend of translational medicine) and the decision to invest into its development (the front end of translational medicine). This chapter provides an overview of this emerging area of research and discusses limitations and research needs. Theoretical concepts and empirical methods for three aspects of THE are presented: First, to analyze “value” for a potential health technology and to apply or to further develop methods for scrutinizing value propositions related to the decision to initiate a translation process; second, to analyze “uncertainty” and to apply or to further develop methods for generating evidence about a health technology's value early on; and third, to analyze barriers of information and motivation in the cooperative process of translation as well as institutions to overcome these. Rather than the traditional concept where health economic evaluations inform health care decision makers about established technologies with established evidence, THE seeks to integrate the development of innovations, and to provide links to health care business perspectives and decisions.
Original languageEnglish
Title of host publicationWorld Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance
EditorsRichard M. Scheffler
PublisherWorld Scientific
Pages405-440
ISBN (Print)9789814612364
DOIs
Publication statusPublished - 2016

Publication series

NameWorld Scientific Series in Global Health Economics and Public Policy
PublisherWorld Scientific

Fingerprint

Health economics
Health technology
Healthcare
Empirical methods
Medicine
Value proposition
Uncertainty
Innovation
Front-end
Economic evaluation
Decision maker

Keywords

  • IR-100326
  • METIS-316589

Cite this

Rogowski, W., John, J., & IJzerman, M. J. (2016). Translational Health Economics. In R. M. Scheffler (Ed.), World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance (pp. 405-440). (World Scientific Series in Global Health Economics and Public Policy). World Scientific. https://doi.org/10.1142/9789813140530_0010
Rogowski, Wolf ; John, Jürgen ; IJzerman, Maarten Joost. / Translational Health Economics. World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance. editor / Richard M. Scheffler. World Scientific, 2016. pp. 405-440 (World Scientific Series in Global Health Economics and Public Policy).
@inbook{2937a278c8ab4110a5cc6bed85422231,
title = "Translational Health Economics",
abstract = "Translational health economics (THE) can be defined as the use of theoretical concepts and empirical methods in health economics to bridge the gap between the decision to fund and use a new health technology in clinical practice (the backend of translational medicine) and the decision to invest into its development (the front end of translational medicine). This chapter provides an overview of this emerging area of research and discusses limitations and research needs. Theoretical concepts and empirical methods for three aspects of THE are presented: First, to analyze “value” for a potential health technology and to apply or to further develop methods for scrutinizing value propositions related to the decision to initiate a translation process; second, to analyze “uncertainty” and to apply or to further develop methods for generating evidence about a health technology's value early on; and third, to analyze barriers of information and motivation in the cooperative process of translation as well as institutions to overcome these. Rather than the traditional concept where health economic evaluations inform health care decision makers about established technologies with established evidence, THE seeks to integrate the development of innovations, and to provide links to health care business perspectives and decisions.",
keywords = "IR-100326, METIS-316589",
author = "Wolf Rogowski and J{\"u}rgen John and IJzerman, {Maarten Joost}",
year = "2016",
doi = "10.1142/9789813140530_0010",
language = "English",
isbn = "9789814612364",
series = "World Scientific Series in Global Health Economics and Public Policy",
publisher = "World Scientific",
pages = "405--440",
editor = "Scheffler, {Richard M.}",
booktitle = "World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance",
address = "United States",

}

Rogowski, W, John, J & IJzerman, MJ 2016, Translational Health Economics. in RM Scheffler (ed.), World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance. World Scientific Series in Global Health Economics and Public Policy, World Scientific, pp. 405-440. https://doi.org/10.1142/9789813140530_0010

Translational Health Economics. / Rogowski, Wolf; John, Jürgen; IJzerman, Maarten Joost.

World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance. ed. / Richard M. Scheffler. World Scientific, 2016. p. 405-440 (World Scientific Series in Global Health Economics and Public Policy).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

TY - CHAP

T1 - Translational Health Economics

AU - Rogowski, Wolf

AU - John, Jürgen

AU - IJzerman, Maarten Joost

PY - 2016

Y1 - 2016

N2 - Translational health economics (THE) can be defined as the use of theoretical concepts and empirical methods in health economics to bridge the gap between the decision to fund and use a new health technology in clinical practice (the backend of translational medicine) and the decision to invest into its development (the front end of translational medicine). This chapter provides an overview of this emerging area of research and discusses limitations and research needs. Theoretical concepts and empirical methods for three aspects of THE are presented: First, to analyze “value” for a potential health technology and to apply or to further develop methods for scrutinizing value propositions related to the decision to initiate a translation process; second, to analyze “uncertainty” and to apply or to further develop methods for generating evidence about a health technology's value early on; and third, to analyze barriers of information and motivation in the cooperative process of translation as well as institutions to overcome these. Rather than the traditional concept where health economic evaluations inform health care decision makers about established technologies with established evidence, THE seeks to integrate the development of innovations, and to provide links to health care business perspectives and decisions.

AB - Translational health economics (THE) can be defined as the use of theoretical concepts and empirical methods in health economics to bridge the gap between the decision to fund and use a new health technology in clinical practice (the backend of translational medicine) and the decision to invest into its development (the front end of translational medicine). This chapter provides an overview of this emerging area of research and discusses limitations and research needs. Theoretical concepts and empirical methods for three aspects of THE are presented: First, to analyze “value” for a potential health technology and to apply or to further develop methods for scrutinizing value propositions related to the decision to initiate a translation process; second, to analyze “uncertainty” and to apply or to further develop methods for generating evidence about a health technology's value early on; and third, to analyze barriers of information and motivation in the cooperative process of translation as well as institutions to overcome these. Rather than the traditional concept where health economic evaluations inform health care decision makers about established technologies with established evidence, THE seeks to integrate the development of innovations, and to provide links to health care business perspectives and decisions.

KW - IR-100326

KW - METIS-316589

U2 - 10.1142/9789813140530_0010

DO - 10.1142/9789813140530_0010

M3 - Chapter

SN - 9789814612364

T3 - World Scientific Series in Global Health Economics and Public Policy

SP - 405

EP - 440

BT - World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance

A2 - Scheffler, Richard M.

PB - World Scientific

ER -

Rogowski W, John J, IJzerman MJ. Translational Health Economics. In Scheffler RM, editor, World Scientific Handbook of Global Health Economics and Public Policy. Volume 3 — Health System Characteristics and Performance. World Scientific. 2016. p. 405-440. (World Scientific Series in Global Health Economics and Public Policy). https://doi.org/10.1142/9789813140530_0010